Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis

Arthritis Rheum. 1987 Oct;30(10):1157-61. doi: 10.1002/art.1780301011.

Abstract

The kinetic interaction between salicylate and naproxen was investigated in 25 rheumatoid arthritis patients. Kinetic interactions were tested in serum after patients had been on each drug regimen for 1 month. Salicylate decreased serum naproxen concentration from 89.5 mg/liter to 65.9 mg/liter (P less than 0.001) and increased serum naproxen clearance by 56%. Naproxen had minimal effect on serum salicylate concentrations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / drug therapy*
  • Choline / analogs & derivatives*
  • Choline / blood
  • Choline / pharmacokinetics
  • Choline / therapeutic use
  • Double-Blind Method
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Metabolic Clearance Rate / drug effects
  • Naproxen / blood
  • Naproxen / pharmacokinetics*
  • Naproxen / therapeutic use
  • Random Allocation
  • Salicylates / blood
  • Salicylates / pharmacokinetics*
  • Salicylates / therapeutic use

Substances

  • Salicylates
  • Naproxen
  • choline magnesium trisalicylate
  • Choline